An observational study in Labor, Premature, sponsored by Assiut University. Status unknown at 2 sites in Egypt. Open to female participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-26.
Sponsored by Assiut University · Observational
During pregnancy , the maternal immune system is always confronted with fetal alloantigens. the immunological mechanisms that prevent the rejection of the fetus are still not under understood.
During pregnancy , the maternal immune system is always confronted with fetal alloantigens. the immunological mechanisms that prevent the rejection of the fetus are still not under understood.the fetus is normally accepted by the maternal immune system despite despite the expression of paternal alloantigens. Normally, the fetus grows and develops very well with ongoing pregnancy.
B regulatory cells are increased in pregnant women compared to non-pregnant women.
255 studies on the registry are indexed under Obstetric Labor, Premature; 38 are open to participants now.
This study's planned enrollment of 90 is below the median of 125 across 85 observational studies indexed under Obstetric Labor, Premature.
Browse Obstetric Labor, Premature studies →Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Healthy term delivery women and preterm labor women
Exclusion Criteria:
Measured by flow cytometry and ELUSA
Dietary Supplement: Investigation
Measured by flow cytometry and ELISA
Dietary Supplement: Investigation
For comparison
Dietary Supplement: Investigation
Cross sectional intervention
Changes in number of B regulatory cell in pregnant woman
Immune system immunosuppressed to maintain fetus
Time frame: 9 months
Plan to share: Undecided — Role of immune system in maintenance of pregnancy
This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University